Apolipoprotein E (APOE) ε4 is the strongest genetic risk factor for Alzheimer's disease (AD). Although its association with AD is well-established, the impact of APOE ε4 on human brain cell function remains unclear. Here we investigated the effects of APOE ε4 on several brain cell types derived from human induced pluripotent stem cells and human APOE targeted replacement mice. Gene set enrichment and pathway analyses of whole transcriptome profiles showed that APOE ε4 is associated with dysregulation of cholesterol homeostasis in human but not mouse astrocytes and microglia. Elevated matrisome signaling associated with chemotaxis, glial activation and lipid biosynthesis in APOE ε4 mixed neuron/astrocyte cultures parallels altered pathways uncovered in cell-type deconvoluted transcriptomic data from APOE ε4 glia and AD postmortem brains. Experimental validation of the transcriptomic findings showed that isogenic APOE ε4 is associated with increased lysosomal cholesterol levels and decreased cholesterol efflux, demonstrating decoupled lipid metabolism. APOE ε4 glia also secrete higher levels of proinflammatory chemokines, cytokines and growth factors, indicative of glial activation. Thus, APOE ε4 induces human glia-specific dysregulation that may initiate AD risk.
increased AD pathology 5 . Although the association between APOE 4 and increased AD risk is well-established, the mechanisms underlying this effect in particular human brain cell types are not entirely clear. Prior studies in mouse models of AD have shown that APOE 4 increases Aβ seeding, decreases Aβ clearance, decreases synaptic plasticity and contributes to blood-brain barrier dysfunction 6, 7 . Targeted replacement mice expressing human APOE (APOE-TR) 4 lack AD pathology with increasing age but exhibit APOE genotype-dependent effects on Aβ deposition and tau-dependent neurodegeneration when crossed with APP or MAPT mutant mouse models 8,9 . While Apoe is normally expressed in astrocytes, recent studies have shown that it is highly upregulated in microglia in the context of the aged or diseased brain. This damage-associated microglial (DAM) polarization state is found near Aβ plaques in APP mice and is Apoedependent [10] [11] [12] . DAM exhibit downregulation of genes that are specifically expressed by microglia in the healthy brain (e.g., P2ry12 and Tgfbr1) and upregulation of genes associated with lipid metabolism (e.g., Apoe and Lpl) and phagocytosis (e.g., Axl and Trem2). However, these studies were performed in the context of mouse Apoe or Apoe knockout (KO), which may differ from the effects of human APOE genotype 13 .
To more broadly address the mechanistic consequences of APOE 4 on human brain cell types, we employed human induced pluripotent stem cells (hiPSCs) generated from AD and control subjects of APOE 44 and APOE 33 genotypes. We examined effects of APOE genotype in microglia, astrocytes (hereinafter glia refers to both astrocytes and microglia) and brain microvascular endothelial cells (BMECs) as well as in mixed cultures of cortical neurons and astrocytes (hereinafter referred to as mixed cortical cultures). To compare the effects of APOE 4 in human and mouse cells, we purified primary microglia and astrocytes from APOE-TR and Apoe KO mice. Global transcriptomic profiling was carried out in each cell type to uncover gene expression changes associated with APOE 4 in human and mouse cells. Gene set enrichment and pathway analyses identified lipid metabolic deficits in APOE 4 hiPSC-glia and brain cell types. Further, cell-type deconvolution of global transcriptomic data from mixed cortical cultures and AD brain tissue homogenates revealed significant enrichment of matrisome pathways associated with chemotaxis, glial activation and lipid metabolism in APOE 4 glia. Finally, in vitro studies demonstrated decoupled cholesterol metabolism in isogenic APOE 44 astrocytes, leading to increased free cholesterol with decreased efflux, resulting in cholesterol accumulation in lysosomes. We further validated enhanced inflammatory chemokine and cytokine secretion from APOE 44 astrocytes. Taken together, our findings reveal APOE 4-driven molecular and cellular mechanisms that may contribute to AD risk.
hiPSC-derived brain cell type differentiation
Thirteen hiPSC lines (derived from six and seven individuals with APOE 44 and 33 genotypes, respectively) were selected from 43 aged individuals of European ancestry, balanced for sex, disease status and controlled for AD genetic risk using a genetic risk score excluding APOE genotype ( Fig. 1a , Extended Data Fig. 1a and Supplemental Data Table 1 ). After confirming the pluripotency and karyotype of the hiPSC lines (Extended Data Fig. 1c-d) , each line was differentiated to four brain cell types: microglia, astrocytes, mixed cortical cultures and BMECs using published protocols [14] [15] [16] [17] [18] (Fig. 1b ). Mixed cortical cultures and astrocytes were differentiated from hiPSC-derived neural progenitor cells as described 14, 15, 18 . Mixed cortical cultures were primarily glutamatergic neurons with a minor portion of GABAergic, TH1+ dopaminergic neurons and astrocytes 14, 18 (Fig. 1e ). Microglia were differentiated from a nearly pure population of CD43 positive hematopoietic progenitor cells (Extended Data Fig. 1e ). BMECs were generated by exposing hiPSCs to endothelial growth factors. These differentiated cells were validated with cell type specific markers ( Fig. 1e ).
To obtain comprehensive transcriptomic profiles for each of the four cell types, RNA sequencing (RNAseq) was performed. Principal component analysis (PCA) and Spearman correlation of the 52 transcriptomes (4 cell types x 13 lines) showed that samples clustered by cell type (Fig. 1c-d ), suggesting that differentiation methods were robust and independent of APOE genotype. Each cell type expressed genes specific to and clustered with their corresponding primary human brain cell types (Extended Data Fig. 1f -g).
Impaired lipid metabolism pathways in human APOE 44 glia
To investigate the effects of APOE 4, differentially expressed gene (DEG) analysis was performed in each hiPSC-derived brain cell type comparing APOE 44 to APOE 33. The number of DEGs in APOE 44 compared to APOE 33 was highest in astrocytes followed by mixed cortical cultures and microglia, no significant DEGs were observed in BMECs ( Fig. 2a-b ). To identify specific pathways affected by APOE 4, we performed fast preranked Gene Set Enrichment Analysis (fGSEA) using Molecular Signature Data Base (MSigDB) which includes canonical pathways, KEGG, Reactome, BioCarta and Gene Ontology (GO)-terms with FDR < 0.2 as a significance threshold 19 , following 1 million gene set permutations. Cholesterol biosynthesis was identified as the most significant and positively enriched gene set in APOE 44 microglia and astrocytes ( Fig. 2c-d ). Other lipid related gene sets such as Steroid biosynthesis (microglia and astrocytes) and Lipid and lipoprotein metabolism (astrocytes) were also enriched. In APOE 44 microglia, negatively enriched gene sets included HDL-mediated lipid transport, Generic transcription and Lysosome.
To determine which molecular and cellular functions, upstream regulators and causal networks of each enriched gene set are altered in APOE 44 compared to APOE 33 glia, we performed causal network analysis of fGSEA-enriched gene sets using Ingenuity Pathway Analysis (IPA) 20 . DEGs of the gene set enriched in Cholesterol biosynthesis is predicted to increase synthesis of cholesterol and terpenoids and upregulate cholesterol and steroid metabolism in APOE 44 compared to APOE 33 microglia ( Fig. 2g ). DEGs of the gene set enriched in Lysosome is predicted to enhance accumulation of cholesterol and decrease lipid clearance and catabolism ( Fig. 2g ). Reduced cholesterol efflux is predicted by a gene set enriched in HDL-mediated lipid transport in APOE 44 microglia ( Fig. 2g ). Likewise, APOE 44 astrocytes show upregulation of cholesterol synthesis and metabolism ( Fig. 2h ). Causal network analysis showed that upstream regulators (e.g. transcription factors regulating cholesterol synthesis 21, 22 ), SCAP and SREBF2 are significantly activated but POR (Cytochrome P450 oxidoreductase) is inhibited in both APOE 44 microglia and astrocytes ( Fig. 2i ). In contrast, the LXR/RXR, lipid-responsive transcription factors that regulate APOE expression and cholesterol efflux, LXR ligands and the NR1H2 and NR1H3 nuclear receptors, are predicted to be downregulated ( Fig. 2j ), suggesting that lipid/cholesterol metabolism and transport may be altered in astrocytes and microglia as a consequence of APOE 44 genotype. The most negatively enriched, Generic transcription pathway in APOE 44 microglia involves inhibition of FXR/RXR activity ( Fig. 2c and Extended Data Fig. 2a ). The causal network of Generic transcription pathway predicts FXR/RXR signaling will be downregulated by decreased low-density lipoprotein (LDL), suggesting suppression of the lipid efflux system due to lower intracellular cholesterols in APOE 44 microglia ( Fig. 2k ). Thus, global transcriptomic analyses reveal that APOE 44 genotype is associated with higher cholesterol synthesis and lower catabolism/efflux, suggesting either that cholesterol levels are lower in APOE 44 cells or that the cholesterol sensing mechanism is impaired in APOE 44 microglia and astrocytes.
In addition, Generic transcriptional pathway in APOE 44 microglia is associated with cell cycle downregulation, leading to decreased cell proliferation and RNA transactivation (Extended Data Fig. 2a-b ). In APOE 44 astrocytes one of the most negatively enriched gene sets is regulation of the actin cytoskeleton ( Fig. 2d ). Interestingly, IPA of this gene set highlights decreased mitosis, mitogenesis and cell cycle progression (proliferation) and increased cell death regulating both apoptosis and necrosis (Extended Data Fig. 2c-d ). It further predicts reduced astrocyte projections, suppressed endocytosis/phagocytosis and decreased cellular homeostasis in APOE 44 glia (Extended Data Fig. 2d ).
Glial origin matrisome gene set/pathway enriched in APOE 44 cells and AD brains
Examination of mixed cortical cultures identified a number of significant DEGs in APOE 44 compared to APOE 33 ( Fig. 2a-b ). Given the heterogeneous nature of these cultures we first measured the proportions of neurons and glia using four different algorithms: digital sorting algorithm (DSA) 23 , population-specific expression analysis (PSEA) 24 , non-negative matrix factorization (ssKL) 25 , and a PCA-based method modified from CellCODE (BRETIGEA, BRain cEll Type specIfic Gene Expression Analysis) 26 (Extended Data Fig. 2e-f ). Although the majority of cells were neurons, all cultures contained 5-25% astrocytes (Extended Data Fig. 2f ). Before and after astrocyte proportion correction in the mixed cortical cultures by DSA, the best fit algorithm validated on primary human brain cell types (Extended Data Fig. 3b ), we found consistent enrichment of matrisome-related pathways including Matrisome associated, Core matrisome and Extracellular matrix (ECM) glycoproteins ( Fig. 2e-f ). After the correction, we also observed significant enrichment of innate immune/cytokine pathways (Fig. 2f ). The in silico 'Matrisome' is defined as the ensemble of ECM proteins and associated factors that are built by compiling proteomics data on the ECM composition 27, 28 . ECM proteins provide biochemical cues interpreted by cell surface receptors like integrins and initiate signaling cascades governing cell survival, proliferation and differentiation 29, 30 . While the 'Core matrisome' comprises ECM glycoproteins, collagens and proteoglycans, 'Matrisome associated' proteins include ECMaffiliated proteins, ECM regulators and secreted factors including growth factors and cytokines released from both neurons and glia 27 . Further analysis of Matrisome associated pathway in APOE 44 mixed cortical cultures showed three functional modules: upregulated chemotaxis of phagocytes/myeloid cells, activation and inflammatory responses of cells and synthesis of lipids ( Fig. 2l ). Additionally, Core matrisome pathway in APOE 44 cells displays increased levels of ECM molecules that support cell attachment and migration (Extended Data Fig. 2g ). The presence of matrisome-related pathways in APOE 44 mixed cortical cultures but not in the pure astrocyte cultures led us to hypothesize that enriched matrisome is associated with communication between neurons and astrocytes 31 and may also be observed in APOE 44 brains.
To determine whether matrisome pathways are also upregulated in human APOE 44 or AD brains, we performed DEG analyses in RNAseq data from the MSBB and ROSMAP cohorts comparing APOE 44 versus (vs) APOE 33 in deconvoluted cell type-specific whole transcriptome profiles of AD brains as well as AD vs control in APOE 33 carriers. Using the cell type proportion estimates, DEG statistics of APOE 44 compared to APOE 33 in each cell type were computed, following deconvolution for each cell type in each brain region using the csSAM algorithm 32 (Extended Data Fig. 3a-c) . Matrisome-related signals were observed in APOE 44 astrocytes from superior temporal gyrus (STG, BA22), parahippocampal gyrus (PHG, BA36) and inferior frontal gyrus (IFG, BA44) in MSBB and dorsolateral prefrontal cortex in ROSMAP from AD brains ( Fig. 3a-e ). Although APOE 44 microglia do not exhibit enriched matrisome pathways, they do show positive enrichment of ECM, chemokine, innate immune and proinflammatory cytokine signaling pathways in all brain regions examined ( Fig. 3f-i ). Next, we tested whether matrisome-related pathways are associated with AD, independent of APOE genotype. Pathway analysis of the brain data within APOE 33 genotype identified that Matrisome and Core matrisome are the most significantly upregulated pathways in AD brains diagnosed by various traits compared to controls (Fig. 3j ). In addition, cell adhesion pathways (ECM/integrin) and inflammatory pathways (cytokine pathways) are positively enriched in AD brains ( Fig. 3j ). Thus, matrisome pathways were strongly enriched in glial cells of APOE 44 carriers and in AD regardless of APOE genotype. Further pathway analysis of DEGs from AD vs control within APOE 33 individuals showed similar modules to those identified in APOE 44 vs APOE 33 mixed cortical cultures ( Fig. 2l and Extended Data Fig. 3n ), indicating that the transcriptomic profile of APOE 44 mixed cortical cultures resembles a phenotype detected in AD compared to control brains regardless of APOE genotype. In addition, combining APOE 44 genotype and AD phenotype effect, we observed significantly enriched matrisome in glia deconvoluted from all brain regions and AD brains (Extended Data Fig. 3d -m).
We also investigated whether pathways enriched in APOE 44 hiPSC-astrocytes and microglia can be identified in APOE 44 human brains (AD or control) in a cell type-specific manner. APOE 44 astrocytes-and microglia-specific whole transcriptome profiles deconvoluted from AD brains showed positive enrichment of Cholesterol/Steroid biosynthesis in astrocytes of frontal cortex (BA10 and ROSMAP) and STG and additional enrichment of Sphingolipid, Phospholipid metabolism in astrocytes of STG and IFG and microglia of PFC ( Fig. 3a -i and Extended Data Fig. 3d -e, 3h-l). It demonstrates that one of the major gene sets enriched in APOE 44 hiPSC-glia is also enriched in APOE 44 brain-transcriptome-deconvoluted glia. The negatively enriched HDL-mediated lipid transport and Lysosome in APOE 44 hiPSC-microglia was also observed in APOE 44 AD microglia of IFG and STG (Fig. 3i ). Further functional predictions reveal that positively enriched gene sets associated with several lipid metabolism pathways in APOE 44 astrocytes and microglia lead to increased synthesis of cholesterol, similar to APOE 44 hiPSCglia ( Fig. 3k-l) . Reduction of lysosomal gene expression in APOE 44 microglia leads to a predicted accumulation of cholesterol and other lipids likely due to decreased catabolism of lipid and cholesterol transport ( Fig. 3m ). Thus, dysregulated transcriptome of lipid metabolism in APOE 44 hiPSC-microglia and cholesterol/steroid synthesis in APOE 44 hiPSC-astrocytes recapitulates changes observed in APOE 44 brain-transcriptome-deconvoluted glia.
Together, our cell type proportion correction, followed by deconvolution of the transcriptome reveal that APOE 44 hiPSC-mixed cortical cultures resemble the transcriptome observed in human AD brains and that the significantly enriched gene sets in both conditions are associated with the support of glial migration, activation and synthesis of lipid, which are derived from APOE 44 glia as a consequence of communication between neurons and glia.
Human specific effects of APOE 44 on glial transcriptomes
Targeted replacement of the endogenous murine Apoe gene with human APOE has been utilized to understand APOE 4 risk in the background of APP or MAPT mutations 9,33 . To unravel mouse glial cell type-specific effects of APOE 4, microglia and astrocytes were purified from 16 mouse fetal brains of APOE 44 (n=6), APOE 33 (n=6) and Apoe KO (n=4) mice. Cell type specific markers were used to confirm purity of the cultures (Fig. 4a ). Clustering analysis of 32 samples (n=16 for each cell type) based on Spearman correlation revealed that they are well-clustered by cell type (Fig. 4b ). PCA analysis shows that APOE 33 and APOE 44 cells cluster together within each cell type, while Apoe KO microglia and astrocytes are well-separated from both APOE 33 and APOE 44 cells (Fig. 4c ). Consistent with human glia, mouse astrocytes have a higher number of DEGs than microglia in APOE 44 vs APOE 33, possibly because APOE is more highly expressed in astrocytes than microglia under the baseline condition used in our experiments ( Fig. 4d and Extended Data Fig. 4a ). After homology conversion of mouse to human DEGs, followed by fGSEA Extended Data Fig. 4c ), we observed that Matrisome associated, ECM affiliated and Interferon/Cytokine/Adaptive immune pathways are enriched in both APOE 44 mouse microglia and astrocytes ( Fig. 4f ). Of note, functional analyses of Matrisome associated pathway in APOE 44 mouse microglia and astrocytes do not exhibit lipid-related dysregulation in contrast to human cells ( Fig. 4i vs Fig. 2l ). This suggests that although APOE 44 mouse glia resemble APOE 44 human glia for enrichment of matrisome and inflammation pathways, lipid metabolic dysregulation appears to be specific to human APOE 44 glia.
Apoe KO exhibits significantly higher number of DEGs (7-9 fold and 4-7 fold) compared to APOE 33 or APOE 44 microglia and astrocytes, respectively ( Fig. 4e and Extended Data Fig. 4ab ). Further assessment of Apoe KO compared to APOE 33 in mouse microglia and astrocytes revealed cell type-specific effects. Apoe KO microglia but not astrocytes display enriched Cholesterol biosynthesis and other lipid regulatory pathways ( Fig. 4g-h ) and further confirm Apoe loss-of-function in regulation of lipid synthesis (Fig. 4j ). In Apoe KO astrocytes, matrisome-related and immune pathways are positively enriched ( Fig. 4h ) but not lipid regulatory functions (Fig. 4k ). Thus, upregulated lipid metabolism is specific to mouse Apoe KO (i.e. absent from APOE 44) microglia, similar to observations in human APOE 44 glia. However, in contrast to human APOE 44 microglia, the Lysosome gene set displays positive enrichment with upregulation of lipid catabolism in mouse Apoe KO microglia and astrocytes ( Fig. 4j-k) . Further analysis of Apoe KO vs APOE 44 DEGs shows consistent results to Apoe KO vs APOE 33 DEGs, demonstrating that Apoe KO-driven dysregulation is distinct from APOE 44 dysregulation in mouse (Extended Data Fig. 4d-e ). Together, these analyses demonstrate that mouse APOE 44 glia partially recapitulate ECM and immune signals but not lipid metabolism dysregulation observed in human APOE 44 glia. Mouse Apoe KO shows distinct transcriptomic dysregulation characterized by upregulation of lysosomal lipid catabolism in both microglia and astrocytes, upregulation of cholesterol synthesis in microglia and upregulation of matrisome pathway in astrocytes.
Elevated cholesterol in APOE 44 hiPSC-astrocytes due to decoupled lipid metabolism
Although we saw consistent differences in the transcriptomic signatures from APOE 44 vs APOE 33 hiPSC-derived neural cultures, there is extensive linkage disequilibrium around the APOE locus, and thus the observed differences cannot be unambiguously attributed solely to APOE genotype. To demonstrate that the changes in cholesterol metabolism, predicted from the global transcriptomic analyses are indeed caused by APOE genotype, we created 12 isogenic APOE hiPSC lines from two APOE 44 individuals using CRISPR/Cas9 gene-editing (Extended Data Fig. 5a-b ). Potential off-targets (quality score ≥ 0.5) using the designed gRNA were confirmed negative, all isogenic lines were karyotypically normal, and their genetic identities matched the original fibroblasts (Supplemental Data Table 6 ).
Since transcriptomic analysis identified pathways consistent with lipid accumulation in human APOE 44 glia, we examined sterol metabolism in vitro. Cellular cholesterol levels measured by Gas Chromatography coupled to Mass Spectrometry (GC-MS) showed 20% increase in total cholesterol and a similar increase in free (or unesterified) cholesterol but not cholesteryl ester levels in APOE 44 compared to isogenic APOE 33 astrocytes (Fig. 5a ), indicating that the increased total cholesterol represents free cholesterol. Consistently, we observed increased filipin levels in APOE 44 compared to APOE 33 astrocytes, indicative of elevated free cholesterol in APOE 44 astrocytes ( Fig. 5b-c) and elevated levels of HMG-CoA reductase (HMGCR), the enzyme responsible for the rate limiting step in cholesterol biosynthesis, in APOE 44 compared to APOE 33 astrocytes ( Fig. 5d-e ). To assess cholesterol accumulation in the presence of excess extracellular lipid, purified LDL particles were added to astrocyte media. Intracellular free cholesterol levels were higher in APOE 44 compared to APOE 33 astrocytes at baseline and after LDL challenge (Fig. 5b-c) , indicating intracellular lipid dysregulation in APOE 44 glia. The average filipin intensity measured per cell by filipin assay is in agreement with differences in free cholesterol measured by GC-MS. The intracellular localization of free cholesterol was observed by co-labeling the astrocytes with filipin and endocytosed FITC-Dextran, a marker for lysosomes. The co-localization of filipin with FITC-Dextran appears as yellow puncta, clearly indicating that free cholesterol is significantly higher in APOE 44 astrocytes and that much of the additional cholesterol is in lysosomes (Fig. 5f) . This phenotype appears to be cell type-specific since the parental fibroblasts do not show a genotype-dependent difference in cholesterol levels (Extended Data Fig. 5d-e ). These findings demonstrate defective cholesterol accumulation in APOE 44 glia.
Next, we examined proteins involved in endo/lysosomal organelles and lipid efflux mechanisms since the transcriptomic data predicts deficits in lysosomal catabolism as well as cholesterol efflux. Consistent with the transcriptomic data showing microglial specific downregulation of genes in the Lysosome gene set including LAMP1, LAMP1 was significantly decreased in APOE 44 microglia but unchanged in astrocytes ( Fig. 5g-j) . Deficiency of LAMP1, which resides in lysosomal/late endosomal membranes and directly binds cholesterol, is associated with a defect in transport of cholesterol to the site of esterification in the endoplasmic reticulum, resulting in intracellular cholesterol accumulation 34, 35 . Of note, APOE 44 astrocytes have much lower levels of both intracellular (80% reduction) and secreted (63% reduction) APOE compared to APOE 33 astrocytes ( Fig. 5f-g) . The ratio of secreted to intracellular APOE was also lower in APOE 44 cells ( Fig. 5k-l ), suggesting decreased efflux of lipids. ATP-binding cassette transporter ABCA1, a major regulator of cellular cholesterol homeostasis through the transport of lipids via APOE, was also significantly decreased in APOE 44 compared to APOE 33 astrocytes ( Fig. 5m-n) .
Taken together, isogenic APOE 44 astrocytes accumulate intracellular free cholesterol but exhibit decreased levels of lipid carriers and transporters with unchanged or lower levels of lysosomal lipid carriers. Combined with the transcriptomic data these results indicate dysregulation of lipid/cholesterol metabolism in APOE 44 glia. Specifically, lipid/cholesterol biosynthesis is elevated and lipid/cholesterol catabolism is decreased in cells that exhibit elevated cholesterol levels, suggesting that cholesterol flux through the lysosome to the endoplasmic reticulum is impaired. In the presence of cholesterol overload, APOE 44 cells take up and accumulate more lipid than APOE 33 cells, even though baseline levels of lipid are already higher. Together, these results suggest that cholesterol metabolism is dysregulated in APOE 44 glia.
Increased chemokines/cytokines profile of isogenic APOE 44 astrocytes
Cell type-deconvolution analysis of AD brain transcriptomes showed a significant enrichment of matrisome-related pathways in APOE 44 astrocytes. To examine this pathway in vitro we measured a panel of secreted proteins that include chemokines, cytokines and growth factors using a Luminex multiplex immunoassay in isogenic human APOE astrocytes. Hierarchical clustering of the data showed that samples are clustered by APOE genotype rather than individual (Extended Data Fig. 6a ). Nearly half of the proteins were differentially expressed by APOE genotype (24 of 45). The top 12 differentially secreted proteins by APOE genotype include the chemokines (SDF-1a (CXCL12), Gro-alpha/KC (CXCL1), MIP-1b (CCL4), Eotaxin (CCL11), IP-10 (CXCL10) and RANTES (CCL5)), cytokines (IL-8, LIF and IL-6) and growth factors (VEGF-A, HGF and VEGF-D) ( Fig. 6a and Extended Data Fig. 6b ). Spearman correlation coefficient analysis of these 12 proteins showed a stronger correlation between these markers in APOE 33 vs APOE 44 astrocytes (Extended Data Fig. 6c-e ). When absolute protein levels were compared between APOE 33 and APOE 44 astrocytes, 10 of these proteins showed significantly higher levels in the media from APOE 44 glia, supporting elevated chemotactic molecules and cytokines in APOE 44 astrocyte transcriptomes.
Concluding remarks
An Apoe-GFP reporter study in mice demonstrated that Apoe is expressed in astrocytes and small subsets of microglia, neurons and endothelial cells at baseline but is increased in microglia and neurons after kainic acid exposure 36 . Single cell RNAseq studies have demonstrated that Apoe is one of the most significantly upregulated genes in a subset of microglia, termed DAM 11 . In mouse models of amyloidosis, these microglia are specifically located around amyloid plaques 12 . KO of Apoe in microglia blocks this polarization in response to damage, indicating that Apoe plays a critical role in these cells, which are characterized at the transcriptomic level by upregulation of phagocytosis and lipid metabolism genes and downregulation of homeostatic genes 10 . In this study, we have used global transcriptomics and in vitro functional studies to determine the impact of human APOE 44 genotype on gene expression and function in four human brain cell types: microglia, astrocytes, mixed cortical cultures and BMECs derived from 13 hiPSC lines of different APOE genotypes and 12 isogenic lines. Human APOE 44 microglia and astrocytes show dysregulation of cholesterol metabolism compared to APOE 33 cells. Specifically, APOE 44 microglia display increased lipid biosynthesis, lipid accumulation and decreased lipid catabolism and efflux, suggesting a decoupling of lipid synthesis and catabolism. Similar pathway dysfunction was observed in APOE 44 glia deconvoluted from human brains derived from multiple AD cohorts.
In APOE 44 hiPSC-mixed cortical cultures compared to APOE 33, matrisome related, ECM, immune pathways were enriched in fGSEA, which replicated findings from brain-transcriptomedeconvoluted APOE 44 glia and AD brains. Upregulation of ECM caused by astrogliosis in brain is associated with accumulation of amyloid plaques in AD and the formation of the glial scar after CNS injuries, which establishes a mechanical barrier inhibiting neurite outgrowth 37, 38 . Thus, the hiPSC-mixed cortical model reveals that the APOE 44 mixed neuronal and glial condition recapitulates some aspects of the AD brain environment and suggests a reactive astrocyte state that upregulates the secretion of ECM, cytokines and growth factors. The DEGs of the Matrisome associated gene set enriched in APOE 44 mixed cortical cultures also showed increased synthesis of lipids that were discovered in pure populations of astrocytes, indicating a link between inflammatory response and lipid synthesis. Comparison of mouse and human glial transcriptomes indicates that mouse APOE 44 glia only partially capture the defects observed in human APOE 44 glia: Matrisome associated, ECM and inflammatory pathways are enriched in APOE 44 mouse microglia and astrocytes but not dysfunction of lipid metabolism pathways, stressing the importance of studying APOE genotype-dependent effects in human model systems. Interestingly, Apoe KO transcriptomes from both microglia and astrocytes were strikingly different from both APOE 33 and APOE 44, which were much more similar to each other. Despite this, DEG analysis of Apoe KO vs APOE 33 and APOE 44 identified many of the same dysregulated pathways seen between APOE 33 and APOE 44 glia.
Niemann-Pick Type C (NPC) is an inherited neurodegenerative disease caused by mutations in either NPC1 or NPC2 that results from a failure of endo/lysosomal cholesterol trafficking, causing lipid accumulation in lysosomes 39 . Although NPC (sometimes referred to as "Childhood Alzheimer's") differs in major respects from AD 40, 41 , our observation of intracellular cholesterol accumulation, particularly in the lysosomes, coupled with decreased lipid efflux in APOE 44 glia, shares similarities with the molecular consequences of NPC loss-of-function, and may represent one of the earliest molecular changes leading to lipidosis in AD 42 .
In summary, we demonstrate human-specific and brain cell type-dependent transcriptional and cellular effects of APOE 44 in hiPSC-derived cultures. Furthermore, these changes mimic APOE 44-dependent transcriptomic changes detected in AD brain and uncover deficits in lipid homeostasis and glial activation. These studies suggest that therapeutic approaches aimed at restoring lipid homeostasis in glia may be beneficial in AD, particularly in APOE 4 carriers.
Figure 1 | Genetic and APOE
genotype based subject selection and brain cell type differentiation. a. Genetic risk score analysis with (left) or without APOE genotype (right) in APOE 33 and 44 lines (n = 13 selected lines out of total n = 43 screened lines) from multiple individual hiPSC lines. CDR, clinical dementia rating. b. Schematics of mixed cortical cultures, astrocytes, microglia and BMECs differentiation derived from APOE 33 and 44 hiPSCs. c. PCA of transcriptomic data from four cell types. d. Spearman correlation analysis of gene expression from 52 differentiated samples (n = 13 per cell type, n = 7 for APOE 33 and n = 6 for APOE 44 in each cell type). e. Representative immunofluoresent images of cell type specific markers for microglia (CX3CR1, IBA1, TREM2, P2RY12 and PU.1), astrocytes (S100B, VIM, NFIA, ALDH1L2, GLAST and AQP4), BMECs (CD5, ZO-1 and Occuludin), neurons (MAP2, TH1, GABA, TUJ1 and NeuN) with astrocytes (S100B, AQP4 and CX43) in mixed cortical cultures confirming cell type differentiations. Scale bar = 100μm. Representative immunoblot images and quantification of LAMP1 in isogenic APOE 33 and APOE 44 microglia (g-h) and astrocytes (i-j). k-l. Representative immunoblot images (k) and quantification (l) of intracellular and secreted APOE and their ratios in isogenic APOE 33 and APOE 44 astrocytes. Raw images for supernatant calculations are in Supplementary fig. 1 . m-n. Representative immunoblot images (m) and quantification (n) of ABCA1 in isogenic APOE astrocytes. Each column in immunoblot images represents an independent CRISPR line per genotype. One-way unpaired t-test for genotype comparisons and One-way ANOVA with Bonferroni post-corrections for comparisons of multiple treatments. *, p < 0.05, **, p < 0.01, ***, p < 0.001. 
